Evidence map›Paper›PMID 36721819›Full record

ArticleAdvanced pharmaceutical bulletin2023

The Potential of Vouacapanes from

Leandra de Almeida Ribeiro Oliveira, Arthur Christian Garcia da Silva, Douglas Vieira Thomaz, Fabiana Brandão, Edemilson Cardoso da Conceição, Marize Campos Valadares, Maria Tereza Freitas Bara, Dâmaris Silveira

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced pharmaceutical bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Leandra de Almeida Ribeiro OliveiraFaculty of Pharmacy, Federal University of Goiás, P.O. Box 131, Goiânia, GO, Brazil.ORCID https://orcid.org/0000-0002-7278-038X
Arthur Christian Garcia da SilvaFaculty of Pharmacy, Federal University of Goiás, P.O. Box 131, Goiânia, GO, Brazil.
Douglas Vieira ThomazFaculty of Pharmacy, Federal University of Goiás, P.O. Box 131, Goiânia, GO, Brazil.ORCID https://orcid.org/0000-0003-0000-3466
Fabiana BrandãoFaculty of Health Sciences, University of Brasilia, Campus Darcy Ribeiro, Asa Norte, 70910-000, DF, Brazil.ORCID https://orcid.org/0000-0001-8358-8062
Edemilson Cardoso da ConceiçãoFaculty of Pharmacy, Federal University of Goiás, P.O. Box 131, Goiânia, GO, Brazil.ORCID https://orcid.org/0000-0003-4113-2686
Marize Campos ValadaresFaculty of Pharmacy, Federal University of Goiás, P.O. Box 131, Goiânia, GO, Brazil.ORCID https://orcid.org/0000-0002-0379-1325
Maria Tereza Freitas BaraFaculty of Pharmacy, Federal University of Goiás, P.O. Box 131, Goiânia, GO, Brazil.ORCID https://orcid.org/0000-0003-4942-8721
Dâmaris SilveiraFaculty of Health Sciences, University of Brasilia, Campus Darcy Ribeiro, Asa Norte, 70910-000, DF, Brazil.ORCID https://orcid.org/0000-0003-1851-5224
Universidade Federal de Goiás · BRUniversidade de Brasília · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoronavirusCOVID-19FuranoditerpeneInflammatory cytokinesSucupira

Identifiers

PMID36721819
PMCPMC9871284
OpenAlexW3208179072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.